| Table/ Topic no. |
Friday, December 5, 2008
Exhibition Area
08:00-09:00 |
Table/ Topic no. |
Saturday, December 6, 2008
Exhibition Area
08:00-09:00 |
| 1 |
Non-contraceptive benefits/risks in oral contraception
Lee Shulman |
1 |
Non-contraceptive benefits/risks in oral contraception
Sue Lo |
| 2 |
Contraception for women with pre-menstrual syndrome/dysphoric disorder
Lorraine Dennerstein |
2 |
Conctraction for women with pre-menstrual syndrome/dysphoric disorder
Surasak Taneepanichskul |
| 3 |
Long-acting methods (injectable, implant, intrauterine)
Biran Affandi |
3 |
Long-activing methods (injectable, implant, intrauterine)
Ian Milsom |
| 4 |
Importance of progestogen component in combined preparations
Alfred Mueck |
4 |
Therapeutic applications for LNG-IUS: The new Millennium option for gynecologic disorders
Osama Shawki |
| 5 |
Reliability of barrier methods
Cherng-Jye Jeng |
5 |
Non-oral hormonal contraception (patch, vaginal rings, subcutaneous implants)
Ritva Hurskainen |
| 6 |
Contraception for the postpartum woman
Grace Wong |
6 |
Reliability of barrier methods
Biran Affandi |
| 7 |
Contraception for the woman after abortion
Im-Soon Lee |
7 |
Contraception for the postpartum woman
Im-Soon Lee |
| 8 |
Contraception and breast cancer (personal history, family history, risk factors)
David Cibula |
8 |
Contraception for the woman after abortion
Xiao Bilian |
| 9 |
Contraception and risk of vascular disease (venous, arterial, other risk factors, smoking, age)
Maureen Cronin |
9 |
Contraception and breast cancer (personal history, family history, risk factors)
Alfred Mueck |
| 10 |
Contraception and the adolescent girl (methods, compliance, risk of sexually-transmitted infection, legal status)
Corazon Raymundo |
10 |
Contraception and risk of vascular disease (venous, arterial, other risk factors, smoking, age)
Maureen Cronin |
| 11 |
Contraception and risk of weight gain (true/false, predisposition, fat distribution, other factors)
Dominic Li |
11 |
Contraception an the adolescent girl (methods, compliance, risk of sexually-transmitted infection, legal status)
Grace Wong |
| 12 |
Choice of contraception for the woman with androgenicity (acne, hirsutes)
Jamiyah Hassan |
12 |
Contraception and risk of weight gain (true/false, predisposition, fat distribution, other factors)
Lee Shulman |
| 13 |
Emergency contraception (methods, availability, educational support)
Sue Lo |
13 |
Choice of contraception for the woman with androgenicity (acne, hirsutes)
David Cibula |
| 14 |
Formal education for the young girl on sexual behaviour, sexuality and contraception (how young, where and when, how much)
Harlina Siraj |
14 |
Emergency contraception (methods, availability, educational support)
Linan Cheng |
| 15 |
Counseling service for contraception (how, where, by whom)
Linan Cheng |
15 |
Formal education for the young girl on sexual behaviour, sexuality and contraception (how young, where and when, how much)
Corazon Raymundo |
| 16 |
Use of evidence to answer questions in contraception (myths, misperceptions, personal bias, media reporting)
Mario Festin |
16 |
Counseling service for contraception (how, where, by whom)
Harlina Siraj |
| 17 |
Use of evidence to answer questions in contraception (myths, misperceptions, personal bias, media reporting)
P.C. Wong |
17 |
Use of evidence to answer questions in contraception (myths, misperections, personal bias, media reporting)
Mario Festin |
| 18 |
Contraception for women over the age of 40 (predisposition, risk factors, benefits, special needs)
Ritva Hurskainen |
18 |
Contraception for women over the age of 40 (predisposition, risk factors, benefits, special needs)
Dominic Li |
| 19 |
Contraception and sexually-transmitted infections (including AIDS)
Cathrine d'Arcangues |
19 |
Contraception and sexually-transmitted infections (including AIDS)
Cathrine d'Arcangues |
| 20 |
Contraception with intrauterine system of hormone delivery (pharmacokinetics, long-term effects, dose range, size of frame, postmenopausal use)
Tapani Luukkainen |
20 |
Contraception with intrauterine system of hormone delivery (pharmacokinetics, long-term effects, dose range, size of frame, postmenopausal use)
Tapani Luukkainen |
| 21 |
Healthcare professionals in partnership with Pharmaceutical industry to provide the best care for women
Phil Smits |
21 |
Partnerships with Schering-Plough: continuing the legacy of Organon Hans Vemer |
| 22 |
The synergy of gynecologists and fertility specialists: helping the infertile patient Hans Vemer |
22 |
Progestogen only methods
Richard Lindgren |
| 23 |
Progestogen only methods
Richard Lindgren |
|
|